1 – 28 of 28
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Emerging role of microRNAs as regulators of protein kinase C substrate MARCKS and MARCKSL1 in cancer
(
- Contribution to journal › Scientific review
- 2023
-
Mark
Venetoclax-Resistant T-ALL Cells Display Distinct Cancer Stem Cell Signatures and Enrichment of Cytokine Signaling
(
- Contribution to journal › Article
-
Mark
P90 ribosomal S6 kinases : A bona fide target for novel targeted anticancer therapies?
(
- Contribution to journal › Scientific review
-
Mark
Biomarkers or biotargets? Using competition to lure cancer cells into evolutionary traps
(
- Contribution to journal › Article
-
Mark
Novel precision medicine approaches and treatment strategies in hematological malignancies
(
- Contribution to journal › Scientific review
- 2022
-
Mark
Comparison of ROS1-rearrangement detection methods in a cohort of surgically resected non-small cell lung carcinomas
(
- Contribution to journal › Article
-
Mark
Targeting SAMHD1 with hydroxyurea in first-line cytarabine-based therapy of newly diagnosed acute myeloid leukaemia : Results from the HEAT-AML trial
(
- Contribution to journal › Article
- 2021
-
Mark
Tumor co-expression of progranulin and sortilin as a prognostic biomarker in breast cancer
(
- Contribution to journal › Article
-
Mark
Precision oncology of high-grade ovarian cancer defined through targeted sequencing
(
- Contribution to journal › Article
-
Mark
A global approach to long-term follow-up of targeted and immune-based therapy in childhood and adolescence
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Randomized Phase II trial of combination chemotherapy with panitumumab or bevacizumab for patients with inoperable biliary tract cancer without KRAS exon 2 mutations
(
- Contribution to journal › Article
-
Mark
Prevalence, Disease-free, and Overall Survival of Contemporary Patients With Renal Cell Carcinoma Eligible for Adjuvant Checkpoint Inhibitor Trials
(
- Contribution to journal › Article
-
Mark
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration-resistant prostate cancer
(
- Contribution to journal › Article
-
Mark
The influence of domain permutations of an albumin-binding domain-fused her2-targeting affibody-based drug conjugate on tumor cell proliferation and therapy efficacy
(
- Contribution to journal › Article
- 2020
-
Mark
The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer
(
- Contribution to journal › Article
-
Mark
LGR5 in breast cancer and ductal carcinoma in situ : a diagnostic and prognostic biomarker and a therapeutic target
(
- Contribution to journal › Article
- 2018
-
Mark
The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence
(
- Contribution to journal › Article
- 2017
-
Mark
Pancreatic cancer stroma : controversies and current insights
(
- Contribution to journal › Scientific review
-
Mark
Perivascular PDGFR-β is an independent marker for prognosis in renal cell carcinoma
(
- Contribution to journal › Article
-
Mark
In vivo immuno-targeting of an extracellular epitope of membrane bound preferentially expressed antigen in melanoma (PRAME)
(
- Contribution to journal › Article
-
Mark
Diagnosis and treatment of brain metastases from solid tumors : Guidelines from the European Association of neuro-oncology (EANO)
(
- Contribution to journal › Article
- 2016
-
Mark
Targeting of non-cycling cells of hypoxic tumors
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Germline mutations of KIT in gastrointestinal stromal tumor (GIST) and mastocytosis
(
- Contribution to journal › Scientific review
-
Mark
Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
(
- Contribution to journal › Article
- 2015
-
Mark
Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network
(
- Contribution to journal › Scientific review
- 2014
-
Mark
Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer
(
- Contribution to journal › Article
- 2010
-
Mark
Burden of metastatic bone disease from genitourinary malignancies
(
- Contribution to journal › Scientific review
- 2008
-
Mark
Gene and Protein Expression in Human Gliomas
(
- Thesis › Doctoral thesis (compilation)